(Q36795634)

16 August 2017

1 reference

title

New therapeutic options for treating type-2 diabetes: a review of insulin analogs and premixed insulin analogs (English)

1 reference

16 August 2017

Charles Choe

1

1 reference

PubMed ID

17444424

16 August 2017

Steve Edelman

series ordinal

2

1 reference

16 August 2017

1 April 2007

1 reference

Journal of the National Medical Association

16 August 2017

1 reference

16 August 2017

99

1 reference

16 August 2017

4

1 reference

16 August 2017

357-60, 363-7

1 reference

ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations

16 August 2017

1 reference

12 December 2020

How can we implement current therapies and interventions to achieve glycemic control?

1 reference

12 December 2020

Treatment models from the International Diabetes Center: advancing from oral agents to insulin therapy in type 2 diabetes.

1 reference

12 December 2020

Patients with poorly controlled diabetes in primary care: healthcare clinicians' beliefs and attitudes

1 reference

12 December 2020

The case for combination therapy as first-line treatment for the type 2 diabetic patient

1 reference

12 December 2020

1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes

1 reference

12 December 2020

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

1 reference

12 December 2020

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

1 reference

12 December 2020

Abstracts of the 66th Scientific Sessions of the American Diabetes Association, June 9-13, 2006, Washington, DC, USA

1 reference

12 December 2020

Combination therapies with insulin in type 2 diabetes

1 reference

12 December 2020

Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen

1 reference

12 December 2020

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

12 December 2020

Loss of early insulin secretion leads to postprandial hyperglycaemia

1 reference

12 December 2020

Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin

1 reference

12 December 2020

Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects

1 reference

12 December 2020

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

12 December 2020

Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents: a randomized controlled trial

1 reference

12 December 2020

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

12 December 2020

A systematic review of adherence with medications for diabetes

1 reference

12 December 2020

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

1 reference

12 December 2020

Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes

1 reference

12 December 2020

The burden of treatment failure in type 2 diabetes

1 reference

12 December 2020

Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop

1 reference

12 December 2020

Towards single-tablet therapy for type 2 diabetes mellitus. Rationale and recent developments

1 reference

12 December 2020

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

1 reference

12 December 2020

Racial and ethnic differences in glycemic control of adults with type 2 diabetes

1 reference

12 December 2020

Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes.

1 reference

12 December 2020

Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

1 reference

12 December 2020

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs

1 reference

12 December 2020

Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations

1 reference

12 December 2020

Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes

1 reference

12 December 2020

Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy

1 reference

12 December 2020

A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp technique

1 reference

12 December 2020

An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives

1 reference

12 December 2020

Insulin delivery using pen devices. Simple-to-use tools may help young and old alike

1 reference

12 December 2020

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

1 reference

12 December 2020

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

1 reference

12 December 2020

Inhaled human insulin treatment in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

12 December 2020

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin

1 reference

12 December 2020

FlexPen: addressing issues of confidence and convenience in insulin delivery

1 reference

12 December 2020

Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial

1 reference

12 December 2020

Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem

1 reference

12 December 2020

Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial

1 reference

12 December 2020

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

1 reference

12 December 2020

Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey

1 reference

12 December 2020

Postprandial glucose regulation: new data and new implications

1 reference

12 December 2020

Identifiers

PubMed ID

17444424

1 reference

PubMed ID

17444424